Exact Mass: 280.1827
Exact Mass Matches: 280.1827
Found 500 metabolites which its exact mass value is equals to given mass value 280.1827,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Imipramine
The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. -- Pubchem; Imipramine (sold as Antideprin, Janimine, Tofranil) is an antidepressant medication, a tricyclic antidepressant of the dibenzazepine group, mainly used in the treatment of clinical depression and enuresis. -- Wikipedia [HMDB] The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. -- Pubchem; Imipramine (sold as Antideprin, Janimine, Tofranil) is an antidepressant medication, a tricyclic antidepressant of the dibenzazepine group, mainly used in the treatment of clinical depression and enuresis. -- Wikipedia. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
12-HHTrE
12(S)-HHTrE is an unusual product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of the human platelet.1 It is biosynthesized by thromboxane (TX) synthesis from prostaglandin H2 (PGH2) concurrently with TXA2. The biological role of 12(S)-HHTrE is uncertain. It is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH. [HMDB] 12(S)-HHTrE is an unusual product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of the human platelet.1 It is biosynthesized by thromboxane (TX) synthesis from prostaglandin H2 (PGH2) concurrently with TXA2. The biological role of 12(S)-HHTrE is uncertain. It is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH.
juvenile hormone III
10,11-epoxy-3,11-dimethyl-7-ethyl-2,6-tridecadienoic acid
brefeldin A
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents A metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.042 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.035 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.034 [Raw Data] CB245_Brefeldin-A_pos_50eV_isCID-10eV_rep000008.txt [Raw Data] CB245_Brefeldin-A_pos_40eV_isCID-10eV_rep000008.txt [Raw Data] CB245_Brefeldin-A_pos_30eV_isCID-10eV_rep000008.txt [Raw Data] CB245_Brefeldin-A_pos_20eV_isCID-10eV_rep000008.txt [Raw Data] CB245_Brefeldin-A_pos_10eV_isCID-10eV_rep000008.txt Brefeldin A (BFA) is a lactone antibiotic and a specific inhibitor of protein trafficking. Brefeldin A blocks the transport of secreted and membrane proteins from endoplasmic reticulum to Golgi apparatus[1][2]. Brefeldin A is also an autophagy and mitophagy inhibitor[3]. Brefeldin A is a CRISPR/Cas9 activator[5]. Brefeldin A inhibits HSV-1 and has anti-cancer activity[5]. Brefeldin A (BFA) is a lactone antibiotic and a specific inhibitor of protein trafficking. Brefeldin A blocks the transport of secreted and membrane proteins from endoplasmic reticulum to Golgi apparatus[1][2]. Brefeldin A is also an autophagy and mitophagy inhibitor[3]. Brefeldin A is a CRISPR/Cas9 activator[5]. Brefeldin A inhibits HSV-1 and has anti-cancer activity[5].
Methyl (3b,11x)-3-Hydroxy-8-oxo-6-eremophilen-12-oate
Methyl (3b,11x)-3-Hydroxy-8-oxo-6-eremophilen-12-oate is found in green vegetables. Methyl (3b,11x)-3-Hydroxy-8-oxo-6-eremophilen-12-oate is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Methyl (3b,11x)-3-Hydroxy-8-oxo-6-eremophilen-12-oate is found in green vegetables.
N-Methylaspidospermatidine
N-Methylaspidospermatidine is an alkaloid in Aspidosperma quebracho-blanco (quebracho
Dihydropanaxacol
Dihydropanaxacol is found in tea. Dihydropanaxacol is present in ginsen Present in ginseng. Dihydropanaxacol is found in tea.
6b-Hydroxy-8a-methoxy-7(11)-eremophilen-12,8-olide
6b-Hydroxy-8a-methoxy-7(11)-eremophilen-12,8-olide is found in green vegetables. 6b-Hydroxy-8a-methoxy-7(11)-eremophilen-12,8-olide is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). 6b-Hydroxy-8a-methoxy-7(11)-eremophilen-12,8-olide is found in green vegetables.
Valeracetate
Constituent of Valeriana officinalis (valerian). Valeracetate is found in tea, fats and oils, and herbs and spices. Valeracetate is found in fats and oils. Valeracetate is a constituent of Valeriana officinalis (valerian).
3b-Hydroxy-6b-methoxy-7(11)-eremophilen-12,8a-olide
3b-Hydroxy-6b-methoxy-7(11)-eremophilen-12,8a-olide is found in green vegetables. 3b-Hydroxy-6b-methoxy-7(11)-eremophilen-12,8a-olide is a constituent of Petasites japonicus (sweet coltsfoot).
Fauronyl acetate
Constituent of root of Valeriana officinalis variety latifolia. Fauronyl acetate is found in tea, fats and oils, and herbs and spices. Fauronyl acetate is found in fats and oils. Fauronyl acetate is a constituent of root of Valeriana officinalis var. latifolia.
Prehumulinic acid
Prehumulinic acid is found in alcoholic beverages. Prehumulinic acid is a constituent of hops Constituent of hops. Prehumulinic acid is found in alcoholic beverages.
3-Methyl-5-propyl-2-furannonanoic acid
3-Methyl-5-propyl-2-furannonanoic acid is a furan fatty acid (F-acid). F-acids are heterocyclic fatty acids containing a central furan moiety with a carboxylalkyl chain (mostly 7, 9, 11, or 13 carbons) in the 2-position and an alkyl chain (mostly 3 or 5 carbons) in the 5-position. Despite being found in low concentrations in food lipids, they are excellent antixoxidants and radical scavengers. This allows them to play an important role in preventing lipid peroxidation and protecting polyunsaturated fatty acids. They are often incorporated into phospholipids and cholesterol esters of fish and other marine organisms. 3-Methyl-5-propyl-2-furannonanoic acid, in particular, can be described by the shorthand notation 9M3. This refers to its 9-carbon carboxyalkyl moiety, the methyl substitution in the 3-position of its furan moiety, and its 3-carbon alkyl moiety.
5-Heptyl-3-methyl-2-furanpentanoic acid
5-Heptyl-3-methyl-2-furanpentanoic acid is a furan fatty acid (F-acid). F-acids are heterocyclic fatty acids containing a central furan moiety with a carboxylalkyl chain (mostly 7, 9, 11, or 13 carbons) in the 2-position and an alkyl chain (mostly 3 or 5 carbons) in the 5-position. Despite being found in low concentrations in food lipids, they are excellent antixoxidants and radical scavengers. This allows them to play an important role in preventing lipid peroxidation and protecting polyunsaturated fatty acids. They are often incorporated into phospholipids and cholesterol esters of fish and other marine organisms. 5-Heptyl-3-methyl-2-furanpentanoic acid, in particular, can be described by the shorthand notation 5M7. This refers to its 5-carbon carboxyalkyl moiety, the methyl substitution in the 3-position of its furan moiety, and its 7-carbon alkyl moiety. It has been identified in the crayfish hepatopancreas.
3-Methyl-5-pentyl-2-furanheptanoic acid
3-Methyl-5-pentyl-2-furanheptanoic acid is a furan fatty acid (F-acid). F-acids are heterocyclic fatty acids containing a central furan moiety with a carboxylalkyl chain (mostly 7, 9, 11, or 13 carbons) in the 2-position and an alkyl chain (mostly 3 or 5 carbons) in the 5-position. Despite being found in low concentrations in food lipids, they are excellent antixoxidants and radical scavengers. This allows them to play an important role in preventing lipid peroxidation and protecting polyunsaturated fatty acids. They are often incorporated into phospholipids and cholesterol esters of fish and other marine organisms. 3-Methyl-5-pentyl-2-furanheptanoic acid, in particular, can be described by the shorthand notation 7M5. This refers to its 7-carbon carboxyalkyl moiety, the methyl substitution in the 3-position of its furan moiety, and its 5-carbon alkyl moiety.
5-Pentyl-2-furanoctanoic acid
5-Pentyl-2-furanoctanoic acid is a furan fatty acid (F-acid). F-acids are heterocyclic fatty acids containing a central furan moiety with a carboxylalkyl chain (mostly 7, 9, 11, or 13 carbons) in the 2-position and an alkyl chain (mostly 3 or 5 carbons) in the 5-position. Despite being found in low concentrations in food lipids, they are excellent antixoxidants and radical scavengers. This allows them to play an important role in preventing lipid peroxidation and protecting polyunsaturated fatty acids. They are often incorporated into phospholipids and cholesterol esters of fish and other marine organisms. 5-Pentyl-2-furanoctanoic acid, in particular, can be described by the shorthand notation 8F5. This refers to its 8-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 5-carbon alkyl moiety. It has been identified in carp.
Histapyrrodine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Histapyrrodine is a first-generation ethylenediamine H1-antihistamine.
(1R,7S,13S,15S)-2,15-Dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
12-Hydroxyheptadeca-5,8,10-trienoic acid
Desmethyltrimipramine
[1S-(1R*,4Z,6R*,11S*)]-4,7,7,11-Tetramethyl-12-oxabicyclo[9.1.0]dodec-4-en-6-ol acetate
[1S-(1R*,4S*,5E,7R*)]-4-Methyl-10-methylene-7-(1-methylethyl)-1-acetate 5-cyclodecene-1,4-diol
[1R-(1alpha,2beta,4abeta,8aalpha)]-1-(Acetyloxy)decahydro-alpha,alpha,4a-trimethyl-8-methylene-2-naphthalenemethanol
(2Z,3S,4S)-2-(11-Dodecenylidene)-3-hydroxy-4-methylbutanolide
1-(2,8-Dihydroxy-1,2,6-trimethyl-1,2,6,7,8,8a-hexahydronaphthalene-1-yl)-3-hydroxypropane-1-one
6-Heptyl-3-methoxy-4-methylene-4,5,6,7a-tetrahydro-furo[2,3-b]pyran-2-one
[1R-(1alpha,4alpha,4aalpha,6alpha,8aalpha)]-1,2,3,4,4a,5,6,8a-Octahydro-4,6-dihydroxy-4,7-dimethyl-a-methylene-1-naphthaleneacetic acid methyl ester
(2S,4S,5S,7S)-10-Hydroxy-7-isopropyl-2-methoxy-4-methyl-1-oxaspiro[4,6]undec-10-en-8-one
5-Ketone,6alpha,7alpha-epoxide,Me ester-Cantabrenonic acid
(5R,7R,10R)-6alpha-acetoxy-eudesm-3-en-7-ol|7alpha-hydroxyeudesm-3-en-6alpha-yl acetate|eudesm-3-ene-6alpha-acetoxy-7alpha-ol
Me ester-5-(1,3-Dihydroxy-2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-2,4-pentadienoic acid
Me ester-5(4鈥樏傗垎3)-Abeo-5-hydroxy-4-oxo-11(13)-eudesmen-12-oic acid|methyl-5beta-hydroxy-4-oxo-11(13)-dehydroiphionoate
8-Hydroxy-10-(5-methyl-4-oxo-2-cyclopenten-1-yl)-9-decenoic acid
8-Ac-3,7,11-Trimethyl-1,6,10-dodecatriene-3,8-diol|8-acetoxynerolidol
7-Oxo-8-carbomethoxypinguisenol|7-oxo-pinguisenol-12-methyl ester|7-Oxopinguisenol-12-methyl ester
3,8-Dimethyl-5-isopropyl-5,8-epoxydecahydroazulene-4-ol acetate
Oplodiolmonoacetat; alpha(r)-1c-Hydroxy-4c-acetoxy-1t,4ar-dimethyl-7-isopropyl-6,7-dehydro-trans-decalin
(-)-4-((2S,4R,6S)-tetrahydro-4-hydroxy-6-pentyl-2H-pyran-2-yl)benzene-1,2-diol|(2S,4R,6S)-2-(3,4-hydroxyphenyl)-4-hydroxy-6-pentyltetrahydropyran
1beta-hydroxy-6alpha-acetoxyeudesm-4(15)-ene|6alpha-acetoxy-1beta-hydroxyeudesm-4(15)-ene
9-acetoxy-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
6beta-methoxy-8beta-hydroxy-eremophil-7(11)-en-12,8alpha-olide
(3E,7E)-6-hydroxy-9-isopropyl-6-methyltrideca-3,7-diene-2,12-dione|6-Hydroxy-9-ispropyl-6-methyl-3,7-tridecadiene-2,12-dione
8-hydroxy-1-methoxy-gamma-butyrolactone dendrolasin
1beta-hydroxy-6beta-acetoxy-eudesm-3-ene|1beta-hydroxy-6beta-acetoxyeudesm-3-ene
(+)-(1R,2R,4R,5R)-4-ethenyl-2-hydroxy-4-methyl-5-(1-methylethenyl)-1-(1-methylethyl)-cyclohexylacetate|7-acetoxy-elema-1,3-dien-8-ol
7-ethyl-5,6-didehydro-20,21-dinor-aspidospermidine|Anhydro-14,15-dihydrocapuronidin
(8betaH)-form-13,14,15,16-Tetranor-1(10)-halimene-12,19-dioic acid|13,14,15,16-tetranorfriedo-1(10)-labden-12,19-dioic acid
Epilaccilahsholinsaeuremethylester|Methyl-epilaccilakscholinat
3alpha,7alpha-dihydroxy amorph-4-ene 3-acetate|3??,7??-Dihydroxy amorph-4-ene 3-acetate
4beta,5alpha-epoxy-6beta-acetoxy-trans-germacr-1(10)-ene
1-Acetoxy-2,2,4-trimethyl-3-(3-methyl-3-hydroxy-4-pentenyl)-4-cyclohexene
2-Methylbutyric acid 2-(2-hydroxy-4-methylphenyl)-2-methoxypropyl ester
(5S)-3-(dodec-11-enyl)-4-hydroxy-5-methylfuran-2(5H)-one|rotundifolide A
(4aR)-Acetoxymethyl-(2R)-isopropyl-(8aR)-methyl-8-oxo-dekalin|(4aR,7R,8aR)-4a-Acetoxymethyl-7-isopropyl-8a-methyl-1-oxo-dekalin|Kanokonylacetat
2,5-dihydroxy-3-methyl-6-nonylcyclohexa-2,5-diene-1,4-dione
(E)-6beta-acetoxy-7alphaH-germacra-1(10),4-diene-2beta-ol
6H,13aH-3a,5a-Ethano-1H-indolizino[8,1-cd]carbazole, 2,3,4,5,11,12-hexahydro-, [10bR-(10bR*,13aS*)]-
kessyl 3-acetate|rel-(1S,2S,3aR,4R,7S,8aR)-decahydro-1,4,9,9-tetramethyl-4,7-(epoxymethano)azulen-2-yl acetate
((1S,4aS,7S,8aS)-7-hydroxy-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)methyl acetate|2(S)-hydroxyalbicanol 11-acetate
(1R,4R,5R,8S,10R)-1-hydroxy-4-methoxyeudesm-7(11)-en-12,8-olide
5alpha-hydroxy-13-methoxy-7alphaH,11alphaH-eudesm-4(15)-en-12,8beta-lactone
(+)-(7S)-7-O-methylsydonic acid|(+)-7-O-methylsydonic acid
(11E,13Z)-1,7-dioxacyclooctadeca-11,13-diene-2,8-dione|mesuadione
6-(2-hydroxyethyl)-2-hydroxymethyl-7-methoxymethyl-2,5-dimethyl-indan-4-ol|russujaponol I
5-Ethyl-5-(3-ethyl-3-(2-methylhexyl)oxiranyl)furan-2(5H)-one
3,8-dihydroxy-heptadeca-9E,15E-dien-11,13-diyne-1-oic acid methyl ester
1beta,8alpha-dihydroxyeudesma-3,5-dien-12-carboxylic acid methyl ester|jatrophaeudesmene A
10beta-hydroxy-8beta-methoxyeremophilenolide|8-Me ether-8,10-Dihydroxy-7(11)-eremophilen-12,8-olide
1beta-hydroxy-6beta-acetoxy-eudesm-4-ene|1beta-hydroxy-6beta-acetoxyeudesm-4-ene
alpha-bisabolol oxide A acetate|Bisabololoxid A-acetat
Me ester-5-(1,4-Dihydroxy-2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-2,4-pentadienoic acid
(3S*,4R*,7S*,1(10)E,5E) 3-acetoxygermacra-1(10),5-dien-4-ol
(-)-(1R,3R,6S,7S,8S,10R)-3-acetoxy-2,2,6,8-tetramethyltricyclo[5.3.1.03,8]undecan-10-one|(6S,7S,8S,10R)-3-hydroxy-2,2,6,8-tetramethyltricyclo[5.3.1.03,8]undec-10-yl acetate|(8R)-8-acetoxypatchoulol|8-acetoxyl-patchouli alcohol|valeriananoid C
(5Z,8E,10E,12S)-12-Hydroxy-5,8,10-heptadecatrienoic acid|(5Z,8E,10E,12S)-12-Hydroxy-5,8,10-heptadecatrienoic acid
2-<<1R-(1alpha,4alpha,5alpha)>-5-Methyl-3-oxo-4-(3-oxobutyl)cyclohexyl>propensaeure-methylester|2-[(1R-(1alpha,4alpha,5alpha))-5-Methyl-3-oxo-4-(3-oxobutyl)cyclohexyl]propensaeure-methylester
7-Hydroxy-heptadecen-(trans-10)-in-(8)-saeure|7-hydroxy-trans-10-heptadecen-8-ynoic acid
11,20-cyclo-aspidospermidine|13-methyl-2,3,4,5,5a,6,11,12-octahydro-1H-3a,11-methano-indolizino[8,1-cd]carbazole|Tuboxenin|vindoline
1alpha,6alpha-dihydroxyisocostic acid methyl ester
3beta-hydroxy-11-acetyldrimene|6beta-Hydroxy-2.5.5.8abeta-tetramethyl-1beta-acetoxymethyl-1.4.4aalpha.5.6.7.8.8a-octahydro-naphthalin
(6S,7R)-12-Acetoxybisabola-1,10E-dien-3-ol|3-Epimer,12-Ac-1,10Bisaboladiene-3,12-diol
7-(2,3-Dimethoxyphenyl)heptansaeuremethylester|methyl 7-(2,3-dimethoxyphenyl)heptanoate
5-Hydroxy-6-methyl-3-(undec-10-enyl)-5,6-dihydropyran-2-one
Me ester-4,5-Dioxo-4,5-seco-11(13)-eudesmen-12-oic acid|methyl-4,5-dioxo-seco-isocostoate
(4aR*,5R*,8aR*,9aS*)-4a,5,6,7,8,8a,9,9a-octahydro-5-hydroxy-9a-methoxy-3,5,8a-trimethylnaphtho[2,3-b]furan-2(4H)-one|4alpha-hydroxy-5alpha(H)-8beta-methoxyeudesm-7(11)-en-8,12-olide
imipramine
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8009; ORIGINAL_PRECURSOR_SCAN_NO 8004 CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8047; ORIGINAL_PRECURSOR_SCAN_NO 8045 CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8055; ORIGINAL_PRECURSOR_SCAN_NO 8052 CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8087; ORIGINAL_PRECURSOR_SCAN_NO 8086 CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8100; ORIGINAL_PRECURSOR_SCAN_NO 8098 CONFIDENCE standard compound; INTERNAL_ID 674; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8102; ORIGINAL_PRECURSOR_SCAN_NO 8100 CONFIDENCE standard compound; INTERNAL_ID 1508
Xylometazoline HCl
Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].
4-hydroxy-1-methoxy-6,6,9a-trimethyl-4,5,5a,7,8,9-hexahydro-1H-benzo[e][2]benzofuran-3-one
C16H24O4_4-Hydroxy-1-methoxy-6,6,9a-trimethyl-4,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-3(1H)-one
C17H28O3_2-Naphthalenemethanol, 7-(acetyloxy)decahydro-alpha,alpha,4a-trimethyl-8-methylene
C16H24O4_[4a-Formyl-5-(hydroxymethyl)-1,2-dimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naphthalenyl]acetic acid
C17H28O3_(1R,2R,4aS,8aS)-2-[(2R)-2-Hydroxybutyl]-1,3-dimethyl-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenecarboxylic acid
(1R,2E,7R,10E,12S,13S,15R)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one
12-HHTrE
A trienoic fatty acid that consists of heptadeca-5,8,10-trienoic acid bearing an additional 12-hydroxy substituent. CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0089.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0089.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0089.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001347.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
(1R,2E,7R,10E,12S,13S,15R)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one_major
(1R,2E,7R,10E,12S,13S,15R)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one_minor
N-Methylaspidospermatidine
6-Hydroxy-8-methoxy-7(11)-eremophilen-12,8-olide
3b-Hydroxy-6b-methoxy-7(11)-eremophilen-12,8a-olide
Methyl (3b,11x)-3-Hydroxy-8-oxo-6-eremophilen-12-oate
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate
Spiro[8-azabicyclo[3.2.1]octane-3,3-pyrrolidine]-8-carboxylic acid, 5-oxo-, 1,1-dimethylethyl ester
Benzene, 1,1-[(2-propenyloxy)methylene]bis[2,6-dimethyl- (9CI)
(1-BIPHENYL-4-YL-2-PYRROLIDIN-1-YL-ETHYL)METHYLAMINE
2-METHYL-5-(6-PHENYLPYRIDAZIN-3-YL)OCTAHYDROPYRROLO[3,4-C]PYRROLE
1-(4-Methoxy-3-(3-Methoxypropoxy)Phenyl)-3-Methylbutan-1-One
2,2-bis(Hydroxymethyl)-1,3-propanediol-2-ethylhexanoate
5-Amino-2-(3-(tert-butylamino)-2-hydroxypropoxy)acetophenone
tert-butyl 4-(imidazol-1-ylmethyl)-1,4-diazepane-1-carboxylate
(2-(2-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)PHENYL)BORONIC ACID
Hydroxytetracaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
4-((TERT-BUTYLDIMETHYLSILYL)OXY)-4-PHENYLBUTAN-1-OL
5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine
2,4,4-trimethylpentan-2-yl 2-phenoxyethaneperoxoate
(+/-)-cis-1-benzyl-3-methyl-N-phenylpiperidinamine
2-([1,1-Biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride
2-methyl-5-(1,4,5,7-tetramethyl-6H-pyrrolo[3,4-d]pyridazin-6-yl)aniline
2,2-Dimethyl-3,6,9,12,15-pentaoxa-2-silahexadecane
2-methyl-5-[(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-4-pyrimidinamine
(+)-(7S)-7-O-methylsydonic acid
A sesquiterpenoid that is the 7-O-methyl derivative of (+)-(7S)-sydonic acid. An Aspergillus metabolite isolated from the sea fan derived fungus Aspergillus sydowii.
1h-Pyrazolo[4,3-b]pyridin-7-amine,5-methyl-n-(2-methylpropyl)-3-phenyl-
bamipine
D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Xylometazoline hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].
histapyrrodine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
2-[4a-Formyl-5-(hydroxymethyl)-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]acetic acid
4-hydroxy-1-methoxy-6,6,9a-trimethyl-4,5,5a,7,8,9-hexahydro-1H-benzo[e][2]benzofuran-3-one
(4S,7S)-4-methyl-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5S,8S)-8-methyl-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(1R,2R,3Z,7S,11E,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
(4S,7R)-4-methyl-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(1R,15S,17S)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene
Methyl (3R,6S)-7-benzyloxy-3-hydroxy-6-methylheptanoate
(1S,2S,3Z,7R,11Z,13R,15R)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
6b-Hydroxy-8a-methoxy-7(11)-eremophilen-12,8-olide
1-[(1as,4s,4as,5s,6s,8s,8as)-6-acetyl-8-hydroxy-4,4a-dimethyl-octahydronaphtho[4,4a-b]oxiren-5-yl]ethanone
(2r)-2-methyl-1-(2,4,6-trimethoxy-3,5-dimethylphenyl)butan-1-one
methyl 2-[(2r,4ar,8ar)-8a-hydroperoxy-4a-methyl-8-methylidene-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
methyl 2-{2-[2-hydroxy-3-(oxiran-2-yl)but-3-en-1-yl]-3,3-dimethylcyclobutyl}prop-2-enoate
(6r,7ar)-6-heptyl-3-methoxy-4-methylidene-5h,6h,7ah-furo[2,3-b]pyran-2-one
methyl 2-[(2r,8ar)-8a-hydroperoxy-4a-methyl-8-methylidene-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
methyl 2-(3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)prop-2-enoate
methyl (4r)-4-[(2s)-6-methyl-4-oxoheptan-2-yl]-3-oxocyclohex-1-ene-1-carboxylate
methyl 2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]prop-2-enoate
3-hydroxy-4-[(2r)-2-methoxy-6-methylheptan-2-yl]benzoic acid
(1r,2s,8s,9s,10r,12r)-8,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
2-[(4s,6s)-6-ethyl-7-hydroxy-4-methylhept-2-en-2-yl]-6-methoxypyran-4-one
(2r,3as,5r)-3a-methoxy-2-(2-methoxypropan-2-yl)-5-(prop-2-en-1-yl)-2,3,4,5-tetrahydro-1-benzofuran-6-one
4-hydroxy-2-(hydroxymethyl)-8,10b-dimethyl-2h,4h,4ah,6ah,7h,8h,9h,10h,10ah-naphtho[2,1-c]pyran-1-one
5-hydroxy-1-(4-hydroxy-2-methoxy-3,6-dimethylphenyl)-2-methylhexan-3-one
4-[(2s,4r,6s)-4-hydroxy-6-pentyloxan-2-yl]benzene-1,2-diol
(4ar,5s,8r,8ar,9ar)-8a-hydroxy-8-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(4ar,5s,8as,9as)-8a-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
(1r,4ar,6as,8r,10ar,10bs)-1-hydroxy-1-(hydroxymethyl)-8,10b-dimethyl-4h,4ah,6ah,7h,8h,9h,10h,10ah-naphtho[2,1-c]pyran-2-one
4-(hydroxymethyl)-3-methoxy-8,12-dimethyl-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-4,11-dien-6-ol
5-(carboxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
methyl 2-[(1r,4r,4ar,6s,8ar)-4,6-dihydroxy-4,7-dimethyl-2,3,4a,5,6,8a-hexahydro-1h-naphthalen-1-yl]prop-2-enoate
2-methoxy-3,5-dimethyl-6-(5-methyl-6-oxoheptyl)pyran-4-one
(1s,2r,5s,9s,10s,12s)-5,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
methyl 2-(1,3-dihydroxy-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl)prop-2-enoate
12,17-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
2-methoxy-3,5-dimethyl-6-[(5r)-5-methyl-6-oxoheptyl]pyran-4-one
2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene
(2z,4e,6z)-8-(acetyloxy)-3,7-dimethylocta-2,4,6-trien-1-yl 2-methylpropanoate
11-Dodecenyl trifluoroacetate
{"Ingredient_id": "HBIN000415","Ingredient_name": "11-Dodecenyl trifluoroacetate","Alias": "dodec-11-enyl 2,2,2-trifluoroacetate; dodec-11-enyl 2,2,2-trifluoroethanoate; 11-Dodecen-1-ol trifluoroacetate; 2,2,2-trifluoroacetic acid dodec-11-enyl ester","Ingredient_formula": "C14H23F3O2","Ingredient_Smile": "C=CCCCCCCCCCCOC(=O)C(F)(F)F","Ingredient_weight": "280.33 g/mol","OB_score": "19.76059422","CAS_id": "NA","SymMap_id": "SMIT12521","TCMID_id": "NA","TCMSP_id": "MOL011650","TCM_ID_id": "NA","PubChem_id": "543399","DrugBank_id": "NA"}
3,6-dihydroxy-7(11)-eremophilen-12,8-olide; (3β,6α,8β,10β)-form,6-me ether
{"Ingredient_id": "HBIN007715","Ingredient_name": "3,6-dihydroxy-7(11)-eremophilen-12,8-olide; (3\u03b2,6\u03b1,8\u03b2,10\u03b2)-form,6-me ether","Alias": "NA","Ingredient_formula": "C16H24O4","Ingredient_Smile": "NA","Ingredient_weight": "280.36","OB_score": "NA","CAS_id": "171595-26-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8242","PubChem_id": "NA","DrugBank_id": "NA"}
3,6-dihydroxy-7(11)-eremophilen-12,8-olide; (3β,6β,8α,10β)-form,6-me ether
{"Ingredient_id": "HBIN007717","Ingredient_name": "3,6-dihydroxy-7(11)-eremophilen-12,8-olide; (3\u03b2,6\u03b2,8\u03b1,10\u03b2)-form,6-me ether","Alias": "NA","Ingredient_formula": "C16H24O4","Ingredient_Smile": "NA","Ingredient_weight": "280.36","OB_score": "NA","CAS_id": "171595-27-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8240","PubChem_id": "NA","DrugBank_id": "NA"}
5alpha,9alpha-Dihydroxymatrine
{"Ingredient_id": "HBIN011398","Ingredient_name": "5alpha,9alpha-Dihydroxymatrine","Alias": "5\u03b1,9\u03b1-dihydroxymatrine; 5alpha,9alpha-dihydroxymatrine","Ingredient_formula": "C15H24N2O3","Ingredient_Smile": "C1CC2C3CC(CN4C3C(CCC4)(CN2C(=O)C1)O)O","Ingredient_weight": "280.41","OB_score": "29.94470231","CAS_id": "NA","SymMap_id": "SMIT01028;SMIT08178","TCMID_id": "25896;5954","TCMSP_id": "MOL001998;MOL006582","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[5]-gingerol
{"Ingredient_id": "HBIN011550","Ingredient_name": "[5]-gingerol","Alias": "NA","Ingredient_formula": "C16H24O4","Ingredient_Smile": "CCCCC(CC(=O)CCC1=CC(=C(C=C1)O)OC)O","Ingredient_weight": "280.36 g/mol","OB_score": "8.105783503","CAS_id": "NA","SymMap_id": "SMIT07794","TCMID_id": "NA","TCMSP_id": "MOL006132","TCM_ID_id": "19289","PubChem_id": "15839352","DrugBank_id": "NA"}
6,8-dihydroxy-3,11(13)-eudesmadien-12-oic acid; (6α,8α)-form,me ester
{"Ingredient_id": "HBIN012120","Ingredient_name": "6,8-dihydroxy-3,11(13)-eudesmadien-12-oic acid; (6\u03b1,8\u03b1)-form,me ester","Alias": "NA","Ingredient_formula": "C16H24O4","Ingredient_Smile": "NA","Ingredient_weight": "280.36","OB_score": "NA","CAS_id": "187523-43-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7605","PubChem_id": "NA","DrugBank_id": "NA"}
